STARGARDT
Clinical trials for STARGARDT explained in plain language.
Never miss a new study
Get alerted when new STARGARDT trials appear
Sign up with your email to follow new studies for STARGARDT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy injection aims to halt blindness in rare eye disorder
Disease control Recruiting nowThis early study tests the safety of a new gene therapy drug, ZVS106e, for people with Stargardt disease, an inherited condition that leads to vision loss. Nine participants aged 8 and older will receive a single injection into the eye. The main goal is to see if the treatment is…
Matched conditions: STARGARDT
Phase: EARLY_PHASE1 • Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New study aims to map stargardt Disease's toll on eyesight
Knowledge-focused Recruiting nowThis study follows 75 people aged 12 to 65 with Stargardt disease type 1, a genetic eye condition that causes vision loss. Researchers will measure changes in the retina and eyesight over time using special imaging and vision tests. The goal is to better understand how the diseas…
Matched conditions: STARGARDT
Sponsor: Splice Bio • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC